Surgical Downstaging in an Open-Label Phase II Trial of Denosumab in Patients with Giant Cell Tumor of Bone

Piotr Rutkowski, Stefano Ferrari, R. J. Grimer, +9

Annals of Surgical Oncology

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis

Zachary Roberts, Nadège Goutagny, Pin‐Yu Perera, +10

The Journal of Experimental Medicine

Safety and Immunogenicity of a Prototype Enterotoxigenic<i>Escherichia coli</i>Vaccine Administered Transcutaneously

Fernando Güereña-Burgueño, Eric R. Hall, David N. Taylor, +6

Infection and Immunity

Microbial PathogensImmunologyImmunodominanceImmunotherapyBacterial Pathogens +16

Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists

Swamy K. Polumuri, Gift Gunaraj Jayakar, Kari Ann Shirey, +4

The Journal of Immunology

Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy

Pei-Hsuan Chen, Mikel Lipschitz, Jason L. Weirather, +10

JCI Insight

Cell TherapyImmunologyImmune RegulationImmunodominanceImmunoediting +19

Macrophage Proinflammatory Response to <i>Francisella tularensis</i> Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways

Leah E. Cole, Araceli E. Santiago, Eileen M. Barry, +6

The Journal of Immunology

End of Phase 1 Results from Zuma-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab for the Treatment of Patients with Refractory Diffuse Large B Cell Lymphoma

Caron A. Jacobson, Frederick L. Locke, David B. Miklos, +8

Blood

Abstract CT055: Phase 1/2 primary analysis of ZUMA-6: Axicabtagene ciloleucel (Axi-Cel) in combination With atezolizumab (Atezo) for the treatment of patients (Pts) with refractory diffuse large B cell lymphoma (DLBCL)

Caron A. Jacobson, Jason R. Westin, David B. Miklos, +10

Cancer Research

Clinical ImmunologyImmunologyImmunoeditingPathologyCd4 T Cell Responses +24

The UNC-6/Netrin receptors UNC-40/DCC and UNC-5 inhibit growth cone filopodial protrusion via UNC-73/Trio, Rac-like GTPases and UNC-33/CRMP

Adam Norris, Lakshmi Sundararajan, Dyan E. Morgan, +2

Development

Molecular RegulationCytoskeletonCell GrowthCellular PhysiologyAxon Repulsion +18

Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone

Jacob Engellau, Leanne L. Seeger, R. J. Grimer, +11

World Journal of Surgical Oncology